The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma

Background: Reliable biomarkers are rare for renal cell carcinoma (RCC) treatment selection. We aimed to discover novel biomarkers for precision medicine. The iron-regulating hormone hepcidin (HAMP) was reportedly increased in RCC patient sera and tissues. However, its potential implication as a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jian, Liu, Wang, Song, Shiqi, Li, Jean C., Gan, Kaimei, Shen, Chunxiao, Holzbeierlein, Jeffrey, Li, Benyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757070/
https://www.ncbi.nlm.nih.gov/pubmed/36532749
http://dx.doi.org/10.3389/fphar.2022.1080055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757070/
https://www.ncbi.nlm.nih.gov/pubmed/36532749
http://dx.doi.org/10.3389/fphar.2022.1080055

Ejemplares similares